Zevra Therapeutics, Inc. Loans Payable, Current
Zevra Therapeutics, Inc. (ZVRA) had Loans Payable, Current of $0 as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:LoansPayableCurrent · last filed 2022-03-31
- 2021-12-31: Loans Payable, Current $0.00.
- 2021-09-30: Loans Payable, Current $0.00.
- 2021-06-30: Loans Payable, Current $0.00.
- 2021-03-31: Loans Payable, Current $683.00K.
| Period end | Loans Payable, Current |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-13 |
| 2021-03-31 | $683.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $390.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |